141
Views
28
CrossRef citations to date
0
Altmetric
Original Research

Chloramphenicol encapsulated in poly-ε-caprolactone–pluronic composite: nanoparticles for treatment of MRSA-infected burn wounds

, , , , , , & show all
Pages 2971-2984 | Published online: 15 Apr 2015

References

  • HorvathEEMurrayCKVaughanGMFungal wound infection (not colonization) is independently associated with mortality in burn patientsAnn Surg2007245697898517522525
  • ChurchDElsayedSReidOWinstonBLindsayRBurn wound infectionsClin Microbiol Rev200619240343416614255
  • AlexisACarrerDPDroggitiDIImmune responses in relation to the type and time of thermal injury: an experimental studyInjury Epub20141031
  • ChamaniaSHemvaniNJoshiSBurn wound infection: Current problem and unmet needsIndian J Burns20122011822
  • LedererJARodrickMLMannickJAThe effects of injury on the adaptive immune responseShock199911315315910188766
  • FongJWoodFNanocrystalline silver dressings in wound management: a reviewInt J Nanomedicine20061444144917722278
  • ZorganiAAShahenAZaidiMFrankaMA profile and spectrum of four cases of methicillin-resistant Staphylococcus aureus in a burns intensive care unitAnn Burns Fire Disasters200619151021991012
  • KatakuraTYoshidaTKobayashiMHerndonDNSuzukiFImmunological control of methicillin-resistant Staphylococcus aureus (MRSA) infection in an immunodeficient murine model of thermal injuriesClin Exp Immunol2005142341942516297152
  • JacobsenFFisahnCSorkinMEfficacy of topically delivered moxifloxacin against wound infection by Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureusAntimicrob Agents Chemother20115552325233421343458
  • FayyazMMirzaIAAhmedZAbbasiSAHussainAAliSIn vitro susceptibility of chloramphenicol against methicillin-resistant Staphylococcus aureusJ Coll Physicians Surg Pak201323963764024034188
  • GovenderTRileyTEhtezaziTDefining the drug incorporation properties of PLA-PEG nanoparticlesInt J Pharm200019919511010794931
  • AtyabiFMoghaddamFADinarvandRZohuriaan-MehrMJPonchelGThiolated chitosan coated poly hydroxyethyl methacrylate nanoparticles: synthesis and characterizationCarbohydr Polym20087415967
  • TingWWVestCDSontheimerRDReview of traditional and novel modalities that enhance the permeability of local therapeutics across the stratum corneumInt J Dermatol200443753854715230899
  • BoninaFPPugliaCBarbuzziTIn vitro and in vivo evaluation of polyoxyethylene esters as dermal prodrugs of ketoprofen, naproxen and diclofenacEur J Pharm Sci200114212313411500258
  • BouchemalKBriançonSPerrierEFessiHBonnetIZydowiczNSynthesis and characterization of polyurethane and poly(ether urethane) nanocapsules using a new technique of interfacial polycondensation combined to spontaneous emulsificationInt J Pharm200426918910014698580
  • ShimJSeok KangHParkWSHanSHKimJChangISTransdermal delivery of mixnoxidil with block copolymer nanoparticlesJ Control Release200497347748415212879
  • Alvarez-RománRNaikAKaliaYNGuyRHFessiHEnhancement of topical delivery from biodegradable nanoparticlesPharm Res200421101818182515553228
  • Alvarez-RománRBarréGGuyRHFessiHBiodegradable polymer nanocapsules containing a sunscreen agent: preparation and photoprotectionEur J Pharm Biopharm200152219119511522485
  • JiménezMMPelletierJBobinMFMartiniMCInfluence of encapsulation on the in vitro percutaneous absorption of octyl methoxycinnamateInt J Pharm20042721–2455515019068
  • MaYZhengYZengXNovel docetaxel-loaded nanoparticles based on PCL-Tween 80 copolymer for cancer treatmentInt J Nanomedicine201162679268822114498
  • KimDYRheeYHBiodegradation of microbial and synthetic polyesters by fungiAppl Microbiol Biotechnol200361430030812743758
  • SuksiriworapongJSriphaKKreuterJJunyaprasertVBFunctionalized (poly(ε-caprolactone))2-poly(ethylene glycol) nanoparticles with grafting nicotinic acid as drug carriersInt J Pharm2012423256257022155410
  • KumariAYadavSKYadavSCBiodegradable polymeric nanoparticles based drug delivery systemsColloids Surf B Biointerfaces201075111819782542
  • DasRKKasojuNBoraUEncapsulation of curcumin in alginate-chitosan-pluronic composite nanoparticles for delivery to cancer cellsNanomedicine20106115316019616123
  • LiPDaiNYZhangJPWangAQWeiQChitosan-alginate nanoparticles as a novel drug delivery system for nifedipineInt J Biomed Sci20084322122823675094
  • SiepmannJPeppasNAModeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC)Adv Drug Deliv Rev2001482–313915711369079
  • PeppasNAAnalysis of Fickian and non-Fickian drug release from polymersPharm Acta Helv19856041101114011621
  • KassemMAElMeshadANFaresARLyophilized sustained release mucoadhesive chitosan sponges for buccal buspirone hydrochloride delivery: formulation and in vitro evaluationAAPS Pharm Sci Tech Epub2014116
  • MathewSTDeviSGKVSFormulation and evaluation of ketorolac tromethamine-loaded albumin microspheres for potential intramuscular administrationAAPS Pharm Sci Tech20078114
  • MosmannTRapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assaysJ Immunol Methods1983651–255636606682
  • YangZGSunHXFangWHHaemolytic activities and adjuvant effect of Astragalus membranaceus saponins (AMS) on the immune responses to ovalbumin in miceVaccine200523445196520316043270
  • KalitaSKumarGKarthikLRaoKVBPhytochemical composition and in vitro hemolytic activity of Lantana camara L. (Verbenaceae) leavesPharmacologyonline Newsletter201115967
  • SerranoDRHernándezLFleireLHemolytic and pharmacokinetic studies of liposomal and particulate amphotericin B formulationsInt J Pharm20134471–2384623438978
  • MuruganKSenthilkumarBSenbagamDAl-SohaibaniSBiosynthesis of silver nanoparticles using Acacia leucophloea extract and their antibacterial activityInt J Nanomedicine201492431243824876776
  • GajbhiyeMKesharwaniJIngleAGadeARaiMFungus-mediated synthesis of silver nanoparticles and their activity against pathogenic fungi in combination with fluconazoleNanomedicine20095438238619616127
  • IrobiONDaramolaSOAntifungal activities of crude extracts of Mitracarpus villosus (Rubiaceae)J Ethnopharmacol19934021371408133654
  • RotimiVOLaughonBEBartletJGMosadomiHAActivities of Nigerian chewing stick extracts against Bacteroides gingivalis and Bacteroides melaninogenicusAntimicrob Agents Chemother19983245986002897830
  • SandeLSanchezMMontesJLiposomal encapsulation of vancomycin improves killing of methicillin-resistant Staphylococcus aureus in a murine infection modelJ Antimicrob Chemother20126792191219422661572
  • SanchezDASchairerDTuckman-VernonCAmphotericin B releasing nanoparticle topical treatment of Candida spp. in the setting of a burn woundNanomedicine201410126927723770066
  • ScholesPDCoombesAGIllumLDetection and determination of surface levels of poloxamer and PVA surfactant on biodegradable nanospheres using SSIMS and XPSJ Control Release199959326127810332059
  • ZhangYTangLSunLA novel paclitaxel-loaded poly(epsilon-caprolactone)/Poloxamer 188 blend nanoparticle overcoming multidrug resistance for cancer treatmentActa Biomater2010662045205219969111
  • AlexisFPridgenEMolnarLKFarokhzadOCFactors affecting the clearance and biodistribution of polymeric nanoparticlesMol Pharm20085450551518672949
  • FlorenceATNanoparticle uptake by the oral route: fulfilling its potential?Drug Discov Today Technol200521758124981758
  • YanFZhangCZhengYThe effect of poloxamer 188 on nanoparticle morphology, size, cancer cell uptake, and cytotoxicityNanomedicine20106117017819447200
  • Clinical and Laboratory Standards Institute (CLSI)Performance standards for antimicrobial susceptibility testing; twenty-second informational supplement (M100-S22)Wayne, PACLSI2012